Amphastar Pharma (AMPH) Stock Price, Quote & News

Company Profile

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin to prevent and treat deep vein thrombosis; REXTOVY and Naloxon...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 909 980 9484

Website: www.amphastar.com

Address:

11570 6th Street, Rancho Cucamonga, United States

StocktwitsEarnings Feb. 26 at 10:00 PM

$AMPH Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.53 down -32.91% YoY • Reported revenue of $183.1M down -1.83% YoY • Amphastar Pharmaceuticals plans to launch Ipratropium Bromide HFA inhalation aerosol in Q2 2026 and expects increased R&D and marketing expenditures, alongside significant capital investments for manufacturing facility expansion.

0 · Reply

StocktwitsEarnings Feb. 26 at 10:00 PM

$AMPH Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.53 down -32.91% YoY • Reported revenue of $183.1M down -1.83% YoY

0 · Reply

EquityInvest Feb. 26 at 9:41 PM

$AMPH yes!!!! Short hit huge!!!!! $$$$$$

0 · Reply

Estimize Feb. 26 at 4:00 PM

$AMPH reports after the close, Estimize Consensus +0.04 EPS and +1.81M Revs compared to WS http://www.estimize.com/amph/fq4-2025?utm_conten

0 · Reply

BillionerOfKing Feb. 25 at 10:18 PM

$AMPH Current Stock Price: $27.96 Contracts to trade: $30.0 AMPH Mar 20 2026 Call Entry: $0.40 Exit: $0.72 ROI: 80% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

EquityInvest Feb. 25 at 3:43 PM

$AMPH 🤣🤣🤣🤣

0 · Reply

EquityInvest Feb. 24 at 4:46 PM

$AMPH no one cares about your boring approval. What is obvious is that you have no pipeline 🤣🤣🤣

0 · Reply

AdLucrum Feb. 24 at 11:45 AM

$AMPH https://finviz.com/news/319826/amphastar-announces-fda-approval-for-ipratropium-bromide-hfa

0 · Reply

CrossSectional Feb. 20 at 1:45 PM

$AMPH Amphastar Pharmaceuticals produces generic and specialty drugs. Margins depend on pricing and manufacturing efficiency. Regulatory risk remains.

0 · Reply

OfficialStocktwitsUser Feb. 18 at 1:48 PM

$AMPH RSI: 68.27, MACD: 0.4528 Vol: 1.20, MA20: 27.44, MA50: 27.05 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 4:05 PM EST - 11 hours ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025

Feb 24, 2026, 6:00 AM EST - 2 days ago

Amphastar Announces FDA Approval for Ipratropium Bromide HFA

Feb 20, 2026, 6:00 AM EST - 6 days ago

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026

Jan 14, 2026, 7:36 PM EST - 6 weeks ago

Amphastar Pharmaceuticals, Inc. (AMPH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 6:00 AM EST - 6 weeks ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Jan 7, 2026, 6:00 AM EST - 7 weeks ago

Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

Dec 15, 2025, 6:00 AM EST - 2 months ago

Amphastar Announces FDA Approval for Teriparatide Injection

Nov 24, 2025, 6:00 AM EST - 3 months ago

Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference

Nov 12, 2025, 6:00 AM EST - 3 months ago

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Nov 8, 2025, 12:16 PM EST - 3 months ago

Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 4 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025

Oct 27, 2025, 6:00 AM EDT - 4 months ago

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025

Sep 23, 2025, 10:06 AM EDT - 5 months ago

After Protracted Sell-Off, Amphastar Looks Like A Value Pick

Aug 28, 2025, 6:00 AM EDT - 6 months ago

Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference

Aug 12, 2025, 1:38 PM EDT - 7 months ago

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum

Aug 12, 2025, 6:00 AM EDT - 7 months ago

Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.

Aug 11, 2025, 6:00 AM EDT - 7 months ago

Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

Aug 8, 2025, 1:40 AM EDT - 7 months ago

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 7 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025

Jul 29, 2025, 9:12 AM EDT - 7 months ago

Amphastar Pharmaceuticals: Shares Are Interesting, And Options Even More

Jul 29, 2025, 6:00 AM EDT - 7 months ago

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025

Jul 14, 2025, 4:05 PM EDT - 8 months ago

Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters

May 11, 2025, 11:32 AM EDT - 10 months ago

Amphastar Pharmaceuticals: Navigating Through An Inflection Year

May 9, 2025, 6:00 AM EDT - 10 months ago

Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference

May 7, 2025, 7:20 PM EDT - 10 months ago

Amphastar Pharmaceuticals Inc. (AMPH) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 10 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

Apr 30, 2025, 6:00 AM EDT - 10 months ago

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025

Apr 3, 2025, 6:00 AM EDT - 11 months ago

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 6:00 AM EDT - 11 months ago

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

Mar 5, 2025, 6:00 AM EST - 1 year ago

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

Feb 28, 2025, 2:15 PM EST - 1 year ago

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds

Feb 27, 2025, 11:04 PM EST - 1 year ago

Amphastar Pharmaceuticals Inc. (AMPH) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:05 PM EST - 1 year ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024

Feb 21, 2025, 2:17 PM EST - 1 year ago

Top 2 Health Care Stocks That May Rocket Higher This Month

WST

Feb 20, 2025, 4:05 PM EST - 1 year ago

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

Feb 19, 2025, 1:09 PM EST - 1 year ago

Amphastar Pharmaceuticals: A Gradual Strategy

Jan 8, 2025, 6:00 AM EST - 1 year ago

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 3, 2025, 12:48 PM EST - 1 year ago

Amphastar Pharmaceuticals: Cheap With Caveats

Nov 26, 2024, 4:05 PM EST - 1 year ago

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

StocktwitsEarnings Feb. 26 at 10:00 PM

0 · Reply

StocktwitsEarnings Feb. 26 at 10:00 PM

$AMPH Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.53 down -32.91% YoY • Reported revenue of $183.1M down -1.83% YoY

0 · Reply

EquityInvest Feb. 26 at 9:41 PM

$AMPH yes!!!! Short hit huge!!!!! $$$$$$

0 · Reply

Estimize Feb. 26 at 4:00 PM

$AMPH reports after the close, Estimize Consensus +0.04 EPS and +1.81M Revs compared to WS http://www.estimize.com/amph/fq4-2025?utm_conten

0 · Reply

BillionerOfKing Feb. 25 at 10:18 PM

0 · Reply

EquityInvest Feb. 25 at 3:43 PM

$AMPH 🤣🤣🤣🤣

0 · Reply

EquityInvest Feb. 24 at 4:46 PM

$AMPH no one cares about your boring approval. What is obvious is that you have no pipeline 🤣🤣🤣

0 · Reply

AdLucrum Feb. 24 at 11:45 AM

$AMPH https://finviz.com/news/319826/amphastar-announces-fda-approval-for-ipratropium-bromide-hfa

0 · Reply

CrossSectional Feb. 20 at 1:45 PM

$AMPH Amphastar Pharmaceuticals produces generic and specialty drugs. Margins depend on pricing and manufacturing efficiency. Regulatory risk remains.

0 · Reply

OfficialStocktwitsUser Feb. 18 at 1:48 PM

0 · Reply

Estimize Feb. 12 at 9:00 PM

Wall St is expecting 0.79 EPS for $AMPH Q1 [Reporting 05/13 AMC] http://www.estimize.com/intro/amph?chart=historical&metric_name=eps&utm_co

0 · Reply

EquityInvest Feb. 12 at 7:37 PM

$AMPH short!!!

0 · Reply

EquityInvest Feb. 12 at 6:48 AM

Fresenius, Phlow link up to boost US epinephrine injection supply $AMPH https://www.fiercepharma.com/manufacturing/fresenius-kabi-and-phlow-ink-us-onshoring-alliance-boost-epinephrine-injection-supply

0 · Reply

BearGrove Feb. 4 at 2:13 PM

$AMPH is a specialty pharmaceutical company focused on hospital injectables; it has a portfolio of niche products but faces pricing pressure and competition.

0 · Reply

SuperGreenToday Jan. 26 at 12:40 PM

$AMPH Share Price: $25.92 Contract Selected: Sep 18, 2026 $35 Calls Buy Zone: $1.03 – $1.28 Target Zone: $1.70 – $2.08 Potential Upside: 56% ROI Time to Expiration: 234 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

BillionerOfKing Jan. 16 at 12:39 PM

$AMPH Current Stock Price: $26.01 Contracts to trade: $25 AMPH Jan 16 2026 Call Entry: $3.74 Exit: $6.95 ROI: 86% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

EquityInvest Jan. 15 at 7:09 PM

$AMPH 😂😂😂

0 · Reply

Arcides Jan. 15 at 6:36 PM

$AMPH was acting good but the last 3 days has being wrecked..not good anymore.

0 · Reply

EquityInvest Jan. 14 at 8:19 PM

$AMPH always love shorting before these morons talk

0 · Reply

QuantCycleInvestor Dec. 27 at 6:21 AM

$AMPH Capital seems to prefer stability in metrics rather than volatile growth spurts. Efficiency gains must convert into measurable results. Sustained improvement may validate the long‑term thesis. As performance stabilizes, the path forward can strengthen.

0 · Reply

JFDI Dec. 17 at 5:29 PM

$AMPH

0 · Reply

EquityInvest Dec. 16 at 2:58 PM

$AMPH 😂😂😂

0 · Reply

Market Cap	1.29B
Revenue (ttm)	731.97M
Net Income (ttm)	159.52M
EPS (ttm)	N/A
PE Ratio	9.16
Forward PE	8.58
Profit Margin	21.79%
Debt to Equity Ratio	0.78

Volume	816,200
Avg Vol	359,770
Day's Range	N/A - N/A
Shares Out	45.95M
Stochastic %K	7%
Beta	0.88
Analysts	Sell
Price Target	$31.57